Gamco Invs Inc Stock Price, News & Analysis

GAMCO Investors (OTCQX: GAMI) sent a letter to Lennar Corporation on October 10, 2025 regarding Lennar’s proposed exchange offer tied to up to 33,298,764 Millrose Properties Class A shares. GAMCO discloses it owns approximately 1,719,782 Lennar Class B shares (5.5%) of 31,217,013 Class B shares outstanding.

GAMCO supports the exchange’s goal to retire equity at an attractive valuation relative to Private Market Value, but objects that Lennar excluded Class B shareholders. GAMCO notes Class B trades at $111.43 while Class A trades at $118.77 (a 7% discount) and urges inclusion of Class B shareholders or permitting conversion to Class A to participate.

Gabelli Asset Management (GAMI) and Columbia Business School will host the 7th Annual Healthcare Symposium on Friday, November 14, 2025 at Convene 237 Park, New York City. This half-day program gathers healthcare executives, clinicians, and investors to discuss four topic panels: multi-cancer screening, beneficiary consumerism, aging in place, and vaccine access and development.

Speakers include executives from Quest Diagnostics, Exact Sciences, Guardant Health, Merck, AbbVie and panel moderators from Gabelli and Columbia. Registration and contact details are provided for investor inquiries.

Gabelli Funds (NYSE:GAMI) will host its 49th Annual Automotive Symposium on November 3–4, 2025 at The Encore at Wynn in Las Vegas, Nevada.

The two-day event features presentations by senior management from automotive OEM suppliers, retailers, aftermarket service providers and next‑gen electrification and tech companies, plus one‑on‑one investor meetings. Topics include tariffs, vehicle affordability, car complexity, autonomous vehicles, and aftermarket resilience. A presenting companies roster and registration link are provided for attendees.

Gabelli Asset Management (NYSE:GAMI) and Columbia Business School will host the 7th Annual Healthcare Symposium on Friday, November 14, 2025 at Convene 237 Park, 237 Park Avenue, New York City. This half-day event convenes healthcare executives, physicians, and investors to discuss trends including multi-cancer screening, consumer-driven beneficiary strategies, aging in place, and vaccine access and development.

The agenda lists timed panels with moderators from Gabelli and Columbia and speakers from Quest Diagnostics, Exact Sciences, Guardant Health, HealthEquity, WEX, Aetna, Oscar Health, InnovAge, SCAN, Signify Health, DispatchHealth, Merck, AbbVie, and Columbia medical/public health faculty. Registration and contact details are provided for attendees.

GAMCO Investors (OTCQX: GAMI) has announced preliminary financial results for Q3 2025. The company expects to report diluted earnings of $0.66 to $0.72 per share, compared to $0.69 per share in Q3 2024. Assets under management (AUM) reached $35.0 billion as of September 30, 2025, up from $32.2 billion year-over-year.

Founded in 1977, GAMCO manages assets for 27 open-end funds, 13 U.S. closed-end funds, 5 actively managed ETFs, and approximately 1,900 institutional and private wealth management investors. The company offers diverse investment solutions across various asset classes, regions, and investment styles. Detailed financial results will be reviewed in early November.

GAMCO Investors (OTCQX: GAMI) has announced its participation in the upcoming Sidoti Small-Cap Conference, scheduled for September 17th, 2025, at 1:45 PM. The presentation will be accessible via webinar registration.

Founded in 1977, Gabelli is a prominent investment advisory firm managing assets across 27 open-end funds, 13 U.S. closed-end funds, 5 actively managed ETFs, and other investment vehicles. The company serves approximately 1,900 institutional and private wealth management investors, primarily in the United States. Gabelli offers diverse investment solutions spanning multiple asset classes, regions, market capitalizations, and investment styles, with its flagship Gabelli Value strategy launched in 1977.

Gabelli Funds (OTCQX: GAMI) has announced its 3rd Annual PFAS Symposium, scheduled for September 17, 2025, at The Harvard Club in New York City. The event will bring together industry leaders, experts, and policymakers to discuss PFAS (Per- and Polyfluoroalkyl Substances) and their environmental impact.

The symposium will feature presentations from various companies including 374Water Inc. (NASDAQ: SCWO), AECOM (NYSE: ACM), and Minerals Technologies (NYSE: MTX), among others. The agenda includes discussions on PFAS uses, replacements, and remediation efforts in water treatment. The event will run from 8:45 AM with opening remarks by Rosemarie Morbelli, CFA, and continue through the afternoon with company presentations and expert discussions.

Gabelli Funds (NYSE:GAMI) announced its 31st Annual Aerospace & Defense Symposium to be held at The Harvard Club in New York City on September 4, 2025. The conference will feature executives from over 17 companies in the aerospace and defense sector.

The symposium will focus on key industry themes including strong demand outlook, high barriers to entry, aftermarket opportunities, above-GDP growth, defense spending, and M&A potential. The event runs from 7:45 AM to 5:00 PM, featuring presentations from notable companies like Textron, HEICO, Moog, and Curtiss-Wright, with opportunities for one-on-one meetings with management teams.

GAMCO Asset Management Inc., an affiliate of GAMCO Investors, Inc. (OTCQX: GAMI), has disclosed ownership of approximately 211,100 shares of Bowlin Travel Centers, Inc. (OTCPK: BWTL). This represents about 5.56% of Bowlin's total 3,797,043 outstanding shares.

Due to Bowlin not being an SEC registrant, GAMCO is using this press release instead of the usual Schedule 13D filing to disclose their ownership position. The company continues to actively purchase BWTL shares and manages assets through various subsidiaries including private advisory accounts and mutual funds.